Navigation Links
Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
Date:9/10/2009

MINNEAPOLIS, Sept. 10 /PRNewswire/ -- Exsulin Corporation today announced the start of a phase II human clinical trial of Exsulin(TM), a peptide drug product aimed at restoring insulin production in people with diabetes mellitus. The randomized, controlled 12-week trial in patients with established Type 1 diabetes (T1DM) will be co-led by Mayo Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, Canada. First results are expected to be available in Q2 2010. The design of the study is based on previous trials which showed improvement in insulin secretion and glucose control in both Type 1 and Type 2 diabetes (T2DM) patients treated with Exsulin.

Diabetes is a life-threatening condition affecting nearly 24 million people in the United States, and more than 200 million worldwide. It remains one of medicine's most significant and costly chronic diseases, and its prevalence is expected to grow due to the global obesity epidemic and the aging of the population. T1DM develops when the body's immune system destroys pancreatic beta cells that make insulin, the key hormone responsible for controlling blood sugar levels. All people with T1DM require insulin therapy to survive. People with T2DM have insufficient insulin secretion and uptake, and often require insulin therapy as their disease progresses. Poorly controlled diabetes can lead to serious complications, including blindness, kidney failure and death.

"Exsulin is a hormone that is being studied for its potential ability to regenerate islets - and possibly restore insulin production -- in the pancreas," said G. Alexander Fleming, MD, founder and chairman, Exsulin Corporation. "We look forward to the results of this important study, which will build on previous findings and further characterize the effects of Exsulin on insulin production and glucose control."

"This phase II tri
'/>"/>

SOURCE Exsulin Corporation
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013  Healthgrades, the leading online resource that ... physicians and hospitals, today issued the Healthgrades ... Healthcare Decisions to Get Your Best Outcome . The ... maternity care, gynecologic surgery, as well as hospitals ... 15 of the most common hospital-based conditions and ...
(Date:6/18/2013)... , June 18, 2013  Isis Pharmaceuticals, Inc. (NASDAQ: ... announced that management will present a general corporate update in ... House on Tuesday, June 25 at 2:10 p.m. Pacific Time ... agenda for the meeting is as follows: 2:00 p.m. – ... record as of April 26, 2013) 2:10 p.m. – 3:15 ...
(Date:6/17/2013)... 17, 2013 DNAtrix Inc., experts in oncolytic ... clinical data on the company,s lead product, DNX-2401, at ... Quebec City, Canada on June 18, 2013. ... and a leader in the field of oncolytic virus ... A PHASE I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS ...
Breaking Medicine Technology:Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2
... Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) and the ... have entered into a research collaboration to enable more ... cancer. The collaboration is based on ... specific spliced viral RNA molecules (i.e., RNA markers) in ...
... SEATTLE, Oct. 8 Throughout October, National Breast Cancer ... and its clinical care partner, the Seattle Cancer Care ... sheets regarding a variety of topics related to breast ... treatment, and survivorship. The series will conclude Friday, Oct. ...
Cached Medicine Technology:Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer 2Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer 310 Tips for Breast Cancer Screening and Early Detection 210 Tips for Breast Cancer Screening and Early Detection 310 Tips for Breast Cancer Screening and Early Detection 4
(Date:6/19/2013)... US Drug Watchdog says, “We have discovered a ... a recipient of a DePuy Pinnacle metal on metal hip ... and chromium, because we believe this the best way short ... the event the cobalt, or chromium levels are elevated we ... to consider, including possible revision surgery to replace the device, ...
(Date:6/19/2013)... National Camp Series (NCS) Associate ... The Dream’s effort to fight ovarian cancer according to NFL ... "We are excited to have Dan jump on board,” says ... young specialists; great example, great purpose. That is exactly what ... Zeidman says Kicking For The Dream is definitely ...
(Date:6/18/2013)... Los Angeles, CA (PRWEB) June 19, 2013 ... field of bariatric surgery, are holding complimentary weight loss ... dates, the detailed program can be accessed at their ... that minimizes surgery and recovery time. Their highly skilled ... approach to bariatric surgery. , A senior executive ...
(Date:6/18/2013)... 19, 2013 Parker Waichman LLP, a ... victims injured by dangerous drugs and medical devices, has ... who alleges that she was injured by transvaginal ... 30th in the U.S. District Court for the Southern ... the multidistrict litigation entitled In Re: American Medical Systems, ...
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
Breaking Medicine News(10 mins):Health News:US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed 2Health News:National Camp Series (NCS) Associate Dan Zeidman of Lifetime Kicking Academy Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer 2Health News:National Camp Series (NCS) Associate Dan Zeidman of Lifetime Kicking Academy Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer 3Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2
... The holiday season can be a time full of joy, ... those recovering from an eating disorder, it,s a time of ... uncertain future. Family gatherings with a loved one in recovery ... , "In my practice, I have even seen ...
... , SAN FRANCISCO, Nov. 24 ... and services provider, announced today that it has licensed ... of Michigan for integration into Quantros, suite of safety ... software within the SRM product family will enable automated ...
... , LAKE SUCCESS, N.Y., Nov. 24 ... certification, an international quality management standard focused on ... improving business performance. Certification to ISO 9001:2008 ... Management System (QMS) has passed a rigorous external ...
... sedatives, antidepressants, benzodiazepines, review finds , TUESDAY, Nov. ... sedatives and other psychotropic medications may be at ... , Canadian researchers analyzed 22 published studies that ... 60. The studies evaluated nine classes of drugs: ...
... Pa., Nov. 24 Governor Edward G. Rendell today ... were vaccinated during the weekend at public health clinics ... departments. , "With the federal government unable to ... H1N1 vaccine, distribution has been challenging," said Governor Rendell. ...
... While the holiday season often brings families and friends ... difficult for those grieving the death of a loved one. ... families. The holiday season can bring additional challenges to those ... for Grieving Children, Adolescents and Their Families, is available for ...
Cached Medicine News:Health News:When Holiday Meals Aren't a Gift 2Health News:When Holiday Meals Aren't a Gift 3Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 2Health News:Quantros Licenses Adverse Event Identification Technology from University of Michigan 3Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Some Prescription Meds May Raise Seniors' Risks of Falling 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2
For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
The Ultra Micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume samples....
... The easy way to order tips. Each ... tips)except for D10mL, which contains 200 tips (4 ... re-sealable Bulk Packs of 200 tips per pack. ... which can easily be opened for quick access ...
... The economical way to order tips. Each ... 1000 tips). Also available in easy-to-open, re-sealable ... Bulk Packs are sealed with a tamper-proof ... quick access to Gilsons Diamond Tips. Bulk ...
Medicine Products: